ADAGE CAPITAL PARTNERS GP LLC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:44 am Sale |
2023-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
ADAGE CAPITAL PARTNERS GP LLC | 1,506,422 2.440% |
-1,964,125 (-56.59%) |
Filing |
| 2023-03-06 4:40 pm Purchase |
2023-02-24 | 13G | Fulcrum Therapeutics, Inc. FULC |
ADAGE CAPITAL PARTNERS GP LLC | 3,470,547 5.630% |
2,350,547 (+209.87%) |
Filing |
| 2023-02-09 11:39 am Sale |
2022-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
ADAGE CAPITAL PARTNERS GP LLC | 1,120,000 2.150% |
-1,030,000 (-47.91%) |
Filing |
| 2022-03-10 4:30 pm Purchase |
2022-02-28 | 13G | Fulcrum Therapeutics, Inc. FULC |
ADAGE CAPITAL PARTNERS GP LLC | 2,150,000 5.290% |
2,150,000 (New Position) |
Filing |